Matrix metallopropteinases in heart failure.
Heart failure (HF) represents a complex multifactorial syndrome, characterized by crucial structural and functional abnormalities of the myocardium. Matrix metalloproteinases are associated with left ventricular dysfunction, adverse left ventricular remodelling and prognosis after acute myocardial i...
Main Authors: | Tousoulis, D, Kampoli, A, Papageorgiou, N, Antoniades, C, Siasos, G, Latsios, G, Tsiamis, E, Stefanadis, C |
---|---|
格式: | Journal article |
語言: | English |
出版: |
2012
|
相似書籍
-
Matrix metalloproteinases in acute coronary syndromes: current perspectives.
由: Kampoli, A, et al.
出版: (2012) -
Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
由: Briasoulis, A, et al.
出版: (2012) -
Circulating biomarkers for the diagnosis and prognosis of heart failure.
由: Tousoulis, D, et al.
出版: (2009) -
Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.
由: Gounari, P, et al.
出版: (2010) -
C-reactive protein and endothelial dysfunction: gazing at the coronaries.
由: Tousoulis, D, et al.
出版: (2011)